Click to watch our Uncovering mpox: The underestimated crisis and its international spread webinar!
In response to the World Health Organization’s declaration of the ongoing mpox outbreak in Africa as a Public Health Emergency of International Concern (PHEIC), BlueDot has enhanced its mpox surveillance offerings. Our upgraded solution delivers real-time insights and intelligence, tailored to monitor Clade I and Clade II separately.
As global surveillance needs intensify, this enhancement enables clients to perform clade-specific risk assessments, monitor clade activity trends, and compare the global spread of each clade. By allowing more robust analyses, public health and enterprise organizations can be better prepared and strengthen their response to the evolving mpox threat.
The WHO’s designation underscores the urgency driven by rising mpox cases, the emergence of a new strain (Clade Ib), and the critical need for coordinated global action. BlueDot has been closely monitoring mpox in the DRC since 2018, providing our clients with timely alerts, intelligence reports, and strategic support.
BlueDot’s Mpox Response To-date:
Clade-Specific Surveillance: BlueDot now offers on-demand surveillance intelligence on Clade I vs. Clade II activity separately, including reported cases, activity trends, and a live stream of relevant news media articles. This enhancement allows for more focused tracking and analysis, which is particularly crucial as Clade I may exhibit more severe symptoms.
Expert-Contextualized Outbreak Updates: For the most recent outbreak BlueDot has already issued 20 Event Alerts, 2 Intelligence reports, and 1 Outbreak Insider starting November 2023, informing clients about the ongoing outbreak and subsequent PHEIC declaration. Our team of experts are actively monitoring the evolving situation and we will continue to provide timely updates as new information becomes available.
Personalized Briefs: BlueDot clients can receive daily updates on global mpox activity tailored to specific locations of interest. Our Personalized Briefs consolidate intelligence from thousands of sources and include our expert-driven rapid risk assessments, trend analyses, and global travel data for informed decision-making.
BlueDot Assistant: BlueDot’s new LLM-powered tool drastically reduces the time spent on horizon scanning by up to 90%. Leveraging BlueDot’s global health and novel datasets in a natural language interface, BlueDot Assistant provides timely answers to critical questions related to the mpox outbreak; such as emerging mpox activity in specific locations, potential for spread to other geographical locations, and more.
As the world faces this pressing public health challenge, BlueDot remains committed to supporting public health organizations with cutting-edge surveillance solutions that enhance their ability to respond effectively to the mpox outbreak.
For more information on our mpox surveillance solution, please get in touch here.
Get the latest updates on the global mpox outbreak
Stay on top of the evolving mpox outbreak – and more – with daily Personalized Briefs, which automatically collect, vet, and consolidate incoming intelligence across thousands of global media and official sources. Featuring rapid risk assessments, newly reported cases per clade, activity trends, and population travel intel, you’ll always be one step ahead.
